Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria

  1. Elizabeth H Aitken
  2. Timon Damelang
  3. Amaya Ortega-Pajares
  4. Agersew Alemu
  5. Wina Hasang
  6. Saber Dini
  7. Holger W Unger
  8. Maria Ome-Kaius
  9. Morten A Nielsen
  10. Ali Salanti
  11. Joe Smith
  12. Stephen Kent
  13. P Mark Hogarth
  14. Bruce D Wines
  15. Julie A Simpson
  16. Amy Chung
  17. Stephen J Rogerson  Is a corresponding author
  1. The University of Melbourne, Australia
  2. Royal Darwin Hospital, Australia
  3. Walter and Eliza Hall Institute of Medical Research, Australia
  4. University of Copenhagen, Denmark
  5. Seattle Children's Research Institute, United States
  6. Burnet Institute, Australia

Abstract

Background: Plasmodium falciparum causes placental malaria, which results in adverse outcomes for mother and child. P. falciparum infected erythrocytes that express the parasite protein VAR2CSA on their surface can bind to placental chondroitin sulfate-A. It has been hypothesized that naturally acquired antibodies towards VAR2CSA protect against placental infection, but it has proven difficult to identify robust antibody correlates of protection from disease. The objective of this study was to develop a prediction model using antibody features which could identify women protected from placental malaria.

Methods: We used a systems serology approach with elastic net-regularized logistic regression, Partial Least Squares Discriminant Analysis and a case control study design to identify naturally acquired antibody features mid pregnancy that were associated with protection from placental malaria at delivery in a cohort of 77 pregnant women from Madang, Papua New Guinea.

Results: The machine learning techniques selected six out of 169 measured antibody features towards VAR2CSA that could predict (with 86% accuracy) whether a woman would subsequently have active placental malaria infection at delivery. Selected features included previously described associations with inhibition of placental binding and/or opsonic phagocytosis of infected erythrocytes, and network analysis indicated that there are not one but multiple pathways to protection from placental malaria.

Conclusions: We have identified candidate antibody features which could accurately identify malaria-infected women as protected from placental infection. It is likely that there are multiple pathways to protection against placental malaria.

Funding: This study was supported by the National Health and Medical Research Council (No. APP1143946, GNT1145303, APP1092789, APP1140509 and APP1104975).

Data availability

All antibody feature data has been deposited in datadryad.

The following data sets were generated

Article and author information

Author details

  1. Elizabeth H Aitken

    Medicine (RMH), The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Timon Damelang

    Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6150-4435
  3. Amaya Ortega-Pajares

    Medicine (RMH), The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Agersew Alemu

    Medicine (RMH), The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Wina Hasang

    Medicine (RMH), The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Saber Dini

    Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Holger W Unger

    Department of Obstetrics and Gynaecology, Royal Darwin Hospital, Darwin, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Maria Ome-Kaius

    Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Morten A Nielsen

    Centre for Medical Parasitology, Department of Microbiology and immunology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2668-4992
  10. Ali Salanti

    Centre for Medical Parasitology, Department of Microbiology and immunology, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  11. Joe Smith

    Centre for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7915-6360
  12. Stephen Kent

    Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  13. P Mark Hogarth

    Burnet Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  14. Bruce D Wines

    Burnet Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  15. Julie A Simpson

    Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2660-2013
  16. Amy Chung

    Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  17. Stephen J Rogerson

    Medicine (RMH), The University of Melbourne, Melbourne, Australia
    For correspondence
    sroger@unimelb.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4287-1982

Funding

National Health and Medical Research Council (APP1143946)

  • Elizabeth H Aitken
  • Amy Chung
  • Stephen J Rogerson

National Health and Medical Research Council (GNT1145303)

  • P Mark Hogarth
  • Bruce D Wines

National Health and Medical Research Council (APP1092789)

  • Stephen J Rogerson

National Health and Medical Research Council (APP1140509)

  • Amy Chung

University of Melbourne

  • Amaya Ortega-Pajares

Australian Society for Parasitology

  • Elizabeth H Aitken

National Health and Medical Research Council (APP1104975)

  • Julie A Simpson

Bill and Melinda Gates Foundation (46099)

  • Stephen J Rogerson

Miller Foundation Australia

  • Amaya Ortega-Pajares

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Urszula Krzych, Walter Reed Army Institute of Research, United States

Ethics

Human subjects: Collection and use of plasma samples from women in PNG was approved by the PNG Institute of Medical Research Institutional Review Board, the PNG Medical Research Advisory Council and the Melbourne Health Human Research Ethics Committee. All participants provided informed written consent. The use of blood products from donors in Melbourne for isolation of primary cells, culture of parasites and leukocytes and for use as negative controls was approved by the Melbourne Health Human Research Ethics committee and the University of Melbourne Human Research Ethics committee.

Version history

  1. Received: December 15, 2020
  2. Accepted: June 16, 2021
  3. Accepted Manuscript published: June 29, 2021 (version 1)
  4. Version of Record published: June 29, 2021 (version 2)
  5. Version of Record updated: August 16, 2021 (version 3)

Copyright

© 2021, Aitken et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,568
    views
  • 199
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elizabeth H Aitken
  2. Timon Damelang
  3. Amaya Ortega-Pajares
  4. Agersew Alemu
  5. Wina Hasang
  6. Saber Dini
  7. Holger W Unger
  8. Maria Ome-Kaius
  9. Morten A Nielsen
  10. Ali Salanti
  11. Joe Smith
  12. Stephen Kent
  13. P Mark Hogarth
  14. Bruce D Wines
  15. Julie A Simpson
  16. Amy Chung
  17. Stephen J Rogerson
(2021)
Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria
eLife 10:e65776.
https://doi.org/10.7554/eLife.65776

Share this article

https://doi.org/10.7554/eLife.65776

Further reading

    1. Evolutionary Biology
    2. Immunology and Inflammation
    Mark S Lee, Peter J Tuohy ... Michael S Kuhns
    Research Advance

    CD4+ T cell activation is driven by five-module receptor complexes. The T cell receptor (TCR) is the receptor module that binds composite surfaces of peptide antigens embedded within MHCII molecules (pMHCII). It associates with three signaling modules (CD3γε, CD3δε, and CD3ζζ) to form TCR-CD3 complexes. CD4 is the coreceptor module. It reciprocally associates with TCR-CD3-pMHCII assemblies on the outside of a CD4+ T cells and with the Src kinase, LCK, on the inside. Previously, we reported that the CD4 transmembrane GGXXG and cytoplasmic juxtamembrane (C/F)CV+C motifs found in eutherian (placental mammal) CD4 have constituent residues that evolved under purifying selection (Lee et al., 2022). Expressing mutants of these motifs together in T cell hybridomas increased CD4-LCK association but reduced CD3ζ, ZAP70, and PLCγ1 phosphorylation levels, as well as IL-2 production, in response to agonist pMHCII. Because these mutants preferentially localized CD4-LCK pairs to non-raft membrane fractions, one explanation for our results was that they impaired proximal signaling by sequestering LCK away from TCR-CD3. An alternative hypothesis is that the mutations directly impacted signaling because the motifs normally play an LCK-independent role in signaling. The goal of this study was to discriminate between these possibilities. Using T cell hybridomas, our results indicate that: intracellular CD4-LCK interactions are not necessary for pMHCII-specific signal initiation; the GGXXG and (C/F)CV+C motifs are key determinants of CD4-mediated pMHCII-specific signal amplification; the GGXXG and (C/F)CV+C motifs exert their functions independently of direct CD4-LCK association. These data provide a mechanistic explanation for why residues within these motifs are under purifying selection in jawed vertebrates. The results are also important to consider for biomimetic engineering of synthetic receptors.

    1. Genetics and Genomics
    2. Immunology and Inflammation
    Jean-David Larouche, Céline M Laumont ... Claude Perreault
    Research Article

    Transposable elements (TEs) are repetitive sequences representing ~45% of the human and mouse genomes and are highly expressed by medullary thymic epithelial cells (mTECs). In this study, we investigated the role of TEs on T-cell development in the thymus. We performed multiomic analyses of TEs in human and mouse thymic cells to elucidate their role in T-cell development. We report that TE expression in the human thymus is high and shows extensive age- and cell lineage-related variations. TE expression correlates with multiple transcription factors in all cell types of the human thymus. Two cell types express particularly broad TE repertoires: mTECs and plasmacytoid dendritic cells (pDCs). In mTECs, transcriptomic data suggest that TEs interact with transcription factors essential for mTEC development and function (e.g., PAX1 and REL), and immunopeptidomic data showed that TEs generate MHC-I-associated peptides implicated in thymocyte education. Notably, AIRE, FEZF2, and CHD4 regulate small yet non-redundant sets of TEs in murine mTECs. Human thymic pDCs homogenously express large numbers of TEs that likely form dsRNA, which can activate innate immune receptors, potentially explaining why thymic pDCs constitutively secrete IFN ɑ/β. This study highlights the diversity of interactions between TEs and the adaptive immune system. TEs are genetic parasites, and the two thymic cell types most affected by TEs (mTEcs and pDCs) are essential to establishing central T-cell tolerance. Therefore, we propose that orchestrating TE expression in thymic cells is critical to prevent autoimmunity in vertebrates.